Cleared Special

K180836 - Genistrong (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Apr 2018
Decision
19d
Days
Class 2
Risk

K180836 is an FDA 510(k) clearance for the Genistrong. Classified as Laparoscope, General & Plastic Surgery (product code GCJ), Class II - Special Controls.

Submitted by Genicon, Inc. (Winter Park, US). The FDA issued a Cleared decision on April 18, 2018 after a review of 19 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1500 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

Submission Details

510(k) Number K180836 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 30, 2018
Decision Date April 18, 2018
Days to Decision 19 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Regulatory Context
Review time vs. panel average
113d faster than avg
Panel avg: 132d · This submission: 19d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code GCJ Laparoscope, General & Plastic Surgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GCJ Laparoscope, General & Plastic Surgery

All 62
Devices cleared under the same product code (GCJ) and FDA review panel - the closest regulatory comparables to K180836.
C-Lant Port
K252714 · Vigor Medical Technologies , Ltd. · Feb 2026
Universal Seal (5-12 mm)
K253978 · Intuitive Surgical, Inc. · Feb 2026
1688 4K Camera System with Advanced Imaging Modality
K260185 · Stryker Endoscopy · Feb 2026
Saberscope™ Laparoscope (SAS-A-536L)
K260177 · Xenocor, Inc. · Feb 2026
Medical Shaver System (Morcellator) (YSB-IIIA)
K251923 · Hangzhou Hawk Optical Electronic Instruments Co., Ltd. · Jan 2026
Pneumo Dissector Hook
K252957 · Ab Medica Sas · Jan 2026